Studies have shown, for example, that HSP-peptide complexes successfully elicited MHC class I restricted cytotoxic T lymphocyte responses, whereas HSP or peptide alone were not immunogenic, establishing the tumor-derived HSP gp96 as the first adjuvant of mammalian origin [24]. This evidence concerns the gene HSP90B2P and neoplasm.